Cell Death & Disease-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2108140, encodeId=f9532108140cb, content=投稿7天 decision made ，现在12天了，not assigned，未收到邮件，是不是拒了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5285325183, createdName=148b8e1fm60暂无昵称, createdTime=Fri Dec 30 13:11:59 CST 2022, time=2022-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2196205, encodeId=f8ea2196205f2, content=偏重的研究方向：免疫;细胞死亡 经验分享：我的Under Consideration 6天就直接Decision Made，这种情况是被拒了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=313a5603215, createdName=ms3000002118315862, createdTime=Sat Mar 30 11:00:33 CST 2024, time=2024-03-30, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2201464, encodeId=5e49220146419, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43d42425724, createdName=123a6632m26暂无昵称, createdTime=Thu May 02 12:46:37 CST 2024, time=12小时前, status=0, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2198923, encodeId=d299219892362, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肺癌;肿瘤生物学 经验分享：从投稿到目前一审回来一共81天，给了 minor revision，目前在狂补实验，希望后面能顺利🙏 时间线变化如下： 2024.01.25：Submission 2024.01.26：Under Consideration，Editor not Assigned 2024.02.15：Editor Assigned 2024.04.09：Decision Made 2024.04.15：出现一个空的进度条，然后当天晚上收到了小修的邮件，给了三周时间修回 目前正在狂补实验，攒攒人品🙏🙏🙏 顺便问一下，这个期刊小修的话二审会送外审吗？着急毕业 (T_T), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220323/c7cf4e6998eb4c7b9c22a01d070c1561/eac82b677dd4471abc7021cc1ba93665.jpg, createdBy=a70d6506235, createdName=Judy Bright, createdTime=Wed Apr 17 10:23:35 CST 2024, time=2024-04-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2173941, encodeId=78ad21e3941c3, content=偏重的研究方向：心血管 经验分享：请大家留言说说一审多久啊，着急毕业，麻烦啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=97525587163, createdName=ms6000000973811944, createdTime=Sat Dec 09 23:54:03 CST 2023, time=2023-12-09, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2147888, encodeId=f2bd214e88842, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：呼吸疾病 经验分享：刚刚中了一篇，比较顺利, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0578477592, createdName=ms7000000921712169, createdTime=Thu Jul 13 19:57:12 CST 2023, time=2023-07-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2199882, encodeId=e3002199882a3, content=想问问大家这个杂志要求的查重率是多少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43d42425724, createdName=123a6632m26暂无昵称, createdTime=Tue Apr 23 01:01:22 CST 2024, time=2024-04-23, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2199775, encodeId=455e2199e75e5, content=偏重的研究方向：死亡;肾癌 经验分享：不容易, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211224/f0f3cc1077304895a307b4b25ddcac07/13b194375f264471bea86cdd211185d4.jpg, createdBy=e8105550250, createdName=Tassel, createdTime=Mon Apr 22 14:22:31 CST 2024, time=2024-04-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2199774, encodeId=968d2199e74d3, content=比较困难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211224/f0f3cc1077304895a307b4b25ddcac07/13b194375f264471bea86cdd211185d4.jpg, createdBy=e8105550250, createdName=Tassel, createdTime=Mon Apr 22 14:20:44 CST 2024, time=2024-04-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2174840, encodeId=c6b921e48403a, content=偏重的研究方向：肿瘤 经验分享：刚submit，沾沾大家的喜气, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4d02501413, createdName=沧海医僧笑, createdTime=Thu Dec 14 01:51:31 CST 2023, time=2023-12-14, status=1, ipAttribution=重庆)]

2022-12-30 148b8e1fm60暂无昵称

投稿7天 decision made ，现在12天了，not assigned，未收到邮件，是不是拒了？

58 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2108140, encodeId=f9532108140cb, content=投稿7天 decision made ，现在12天了，not assigned，未收到邮件，是不是拒了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5285325183, createdName=148b8e1fm60暂无昵称, createdTime=Fri Dec 30 13:11:59 CST 2022, time=2022-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2196205, encodeId=f8ea2196205f2, content=偏重的研究方向：免疫;细胞死亡 经验分享：我的Under Consideration 6天就直接Decision Made，这种情况是被拒了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=313a5603215, createdName=ms3000002118315862, createdTime=Sat Mar 30 11:00:33 CST 2024, time=2024-03-30, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2201464, encodeId=5e49220146419, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43d42425724, createdName=123a6632m26暂无昵称, createdTime=Thu May 02 12:46:37 CST 2024, time=12小时前, status=0, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2198923, encodeId=d299219892362, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肺癌;肿瘤生物学 经验分享：从投稿到目前一审回来一共81天，给了 minor revision，目前在狂补实验，希望后面能顺利🙏 时间线变化如下： 2024.01.25：Submission 2024.01.26：Under Consideration，Editor not Assigned 2024.02.15：Editor Assigned 2024.04.09：Decision Made 2024.04.15：出现一个空的进度条，然后当天晚上收到了小修的邮件，给了三周时间修回 目前正在狂补实验，攒攒人品🙏🙏🙏 顺便问一下，这个期刊小修的话二审会送外审吗？着急毕业 (T_T), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220323/c7cf4e6998eb4c7b9c22a01d070c1561/eac82b677dd4471abc7021cc1ba93665.jpg, createdBy=a70d6506235, createdName=Judy Bright, createdTime=Wed Apr 17 10:23:35 CST 2024, time=2024-04-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2173941, encodeId=78ad21e3941c3, content=偏重的研究方向：心血管 经验分享：请大家留言说说一审多久啊，着急毕业，麻烦啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=97525587163, createdName=ms6000000973811944, createdTime=Sat Dec 09 23:54:03 CST 2023, time=2023-12-09, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2147888, encodeId=f2bd214e88842, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：呼吸疾病 经验分享：刚刚中了一篇，比较顺利, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0578477592, createdName=ms7000000921712169, createdTime=Thu Jul 13 19:57:12 CST 2023, time=2023-07-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2199882, encodeId=e3002199882a3, content=想问问大家这个杂志要求的查重率是多少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43d42425724, createdName=123a6632m26暂无昵称, createdTime=Tue Apr 23 01:01:22 CST 2024, time=2024-04-23, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2199775, encodeId=455e2199e75e5, content=偏重的研究方向：死亡;肾癌 经验分享：不容易, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211224/f0f3cc1077304895a307b4b25ddcac07/13b194375f264471bea86cdd211185d4.jpg, createdBy=e8105550250, createdName=Tassel, createdTime=Mon Apr 22 14:22:31 CST 2024, time=2024-04-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2199774, encodeId=968d2199e74d3, content=比较困难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211224/f0f3cc1077304895a307b4b25ddcac07/13b194375f264471bea86cdd211185d4.jpg, createdBy=e8105550250, createdName=Tassel, createdTime=Mon Apr 22 14:20:44 CST 2024, time=2024-04-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2174840, encodeId=c6b921e48403a, content=偏重的研究方向：肿瘤 经验分享：刚submit，沾沾大家的喜气, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4d02501413, createdName=沧海医僧笑, createdTime=Thu Dec 14 01:51:31 CST 2023, time=2023-12-14, status=1, ipAttribution=重庆)]

2024-03-30 ms3000002118315862 来自广东省

偏重的研究方向：免疫;细胞死亡
经验分享：我的Under Consideration 6天就直接Decision Made，这种情况是被拒了吗

12 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2108140, encodeId=f9532108140cb, content=投稿7天 decision made ，现在12天了，not assigned，未收到邮件，是不是拒了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5285325183, createdName=148b8e1fm60暂无昵称, createdTime=Fri Dec 30 13:11:59 CST 2022, time=2022-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2196205, encodeId=f8ea2196205f2, content=偏重的研究方向：免疫;细胞死亡 经验分享：我的Under Consideration 6天就直接Decision Made，这种情况是被拒了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=313a5603215, createdName=ms3000002118315862, createdTime=Sat Mar 30 11:00:33 CST 2024, time=2024-03-30, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2201464, encodeId=5e49220146419, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43d42425724, createdName=123a6632m26暂无昵称, createdTime=Thu May 02 12:46:37 CST 2024, time=12小时前, status=0, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2198923, encodeId=d299219892362, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肺癌;肿瘤生物学 经验分享：从投稿到目前一审回来一共81天，给了 minor revision，目前在狂补实验，希望后面能顺利🙏 时间线变化如下： 2024.01.25：Submission 2024.01.26：Under Consideration，Editor not Assigned 2024.02.15：Editor Assigned 2024.04.09：Decision Made 2024.04.15：出现一个空的进度条，然后当天晚上收到了小修的邮件，给了三周时间修回 目前正在狂补实验，攒攒人品🙏🙏🙏 顺便问一下，这个期刊小修的话二审会送外审吗？着急毕业 (T_T), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220323/c7cf4e6998eb4c7b9c22a01d070c1561/eac82b677dd4471abc7021cc1ba93665.jpg, createdBy=a70d6506235, createdName=Judy Bright, createdTime=Wed Apr 17 10:23:35 CST 2024, time=2024-04-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2173941, encodeId=78ad21e3941c3, content=偏重的研究方向：心血管 经验分享：请大家留言说说一审多久啊，着急毕业，麻烦啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=97525587163, createdName=ms6000000973811944, createdTime=Sat Dec 09 23:54:03 CST 2023, time=2023-12-09, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2147888, encodeId=f2bd214e88842, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：呼吸疾病 经验分享：刚刚中了一篇，比较顺利, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0578477592, createdName=ms7000000921712169, createdTime=Thu Jul 13 19:57:12 CST 2023, time=2023-07-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2199882, encodeId=e3002199882a3, content=想问问大家这个杂志要求的查重率是多少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43d42425724, createdName=123a6632m26暂无昵称, createdTime=Tue Apr 23 01:01:22 CST 2024, time=2024-04-23, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2199775, encodeId=455e2199e75e5, content=偏重的研究方向：死亡;肾癌 经验分享：不容易, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211224/f0f3cc1077304895a307b4b25ddcac07/13b194375f264471bea86cdd211185d4.jpg, createdBy=e8105550250, createdName=Tassel, createdTime=Mon Apr 22 14:22:31 CST 2024, time=2024-04-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2199774, encodeId=968d2199e74d3, content=比较困难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211224/f0f3cc1077304895a307b4b25ddcac07/13b194375f264471bea86cdd211185d4.jpg, createdBy=e8105550250, createdName=Tassel, createdTime=Mon Apr 22 14:20:44 CST 2024, time=2024-04-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2174840, encodeId=c6b921e48403a, content=偏重的研究方向：肿瘤 经验分享：刚submit，沾沾大家的喜气, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4d02501413, createdName=沧海医僧笑, createdTime=Thu Dec 14 01:51:31 CST 2023, time=2023-12-14, status=1, ipAttribution=重庆)]

12小时前 123a6632m26暂无昵称来自辽宁省

前往app查看评论内容

0 0

[GetPortalCommentsPageByObjectIdResponse(id=2108140, encodeId=f9532108140cb, content=投稿7天 decision made ，现在12天了，not assigned，未收到邮件，是不是拒了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5285325183, createdName=148b8e1fm60暂无昵称, createdTime=Fri Dec 30 13:11:59 CST 2022, time=2022-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2196205, encodeId=f8ea2196205f2, content=偏重的研究方向：免疫;细胞死亡 经验分享：我的Under Consideration 6天就直接Decision Made，这种情况是被拒了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=313a5603215, createdName=ms3000002118315862, createdTime=Sat Mar 30 11:00:33 CST 2024, time=2024-03-30, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2201464, encodeId=5e49220146419, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43d42425724, createdName=123a6632m26暂无昵称, createdTime=Thu May 02 12:46:37 CST 2024, time=12小时前, status=0, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2198923, encodeId=d299219892362, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肺癌;肿瘤生物学 经验分享：从投稿到目前一审回来一共81天，给了 minor revision，目前在狂补实验，希望后面能顺利🙏 时间线变化如下： 2024.01.25：Submission 2024.01.26：Under Consideration，Editor not Assigned 2024.02.15：Editor Assigned 2024.04.09：Decision Made 2024.04.15：出现一个空的进度条，然后当天晚上收到了小修的邮件，给了三周时间修回 目前正在狂补实验，攒攒人品🙏🙏🙏 顺便问一下，这个期刊小修的话二审会送外审吗？着急毕业 (T_T), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220323/c7cf4e6998eb4c7b9c22a01d070c1561/eac82b677dd4471abc7021cc1ba93665.jpg, createdBy=a70d6506235, createdName=Judy Bright, createdTime=Wed Apr 17 10:23:35 CST 2024, time=2024-04-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2173941, encodeId=78ad21e3941c3, content=偏重的研究方向：心血管 经验分享：请大家留言说说一审多久啊，着急毕业，麻烦啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=97525587163, createdName=ms6000000973811944, createdTime=Sat Dec 09 23:54:03 CST 2023, time=2023-12-09, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2147888, encodeId=f2bd214e88842, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：呼吸疾病 经验分享：刚刚中了一篇，比较顺利, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0578477592, createdName=ms7000000921712169, createdTime=Thu Jul 13 19:57:12 CST 2023, time=2023-07-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2199882, encodeId=e3002199882a3, content=想问问大家这个杂志要求的查重率是多少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43d42425724, createdName=123a6632m26暂无昵称, createdTime=Tue Apr 23 01:01:22 CST 2024, time=2024-04-23, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2199775, encodeId=455e2199e75e5, content=偏重的研究方向：死亡;肾癌 经验分享：不容易, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211224/f0f3cc1077304895a307b4b25ddcac07/13b194375f264471bea86cdd211185d4.jpg, createdBy=e8105550250, createdName=Tassel, createdTime=Mon Apr 22 14:22:31 CST 2024, time=2024-04-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2199774, encodeId=968d2199e74d3, content=比较困难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211224/f0f3cc1077304895a307b4b25ddcac07/13b194375f264471bea86cdd211185d4.jpg, createdBy=e8105550250, createdName=Tassel, createdTime=Mon Apr 22 14:20:44 CST 2024, time=2024-04-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2174840, encodeId=c6b921e48403a, content=偏重的研究方向：肿瘤 经验分享：刚submit，沾沾大家的喜气, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4d02501413, createdName=沧海医僧笑, createdTime=Thu Dec 14 01:51:31 CST 2023, time=2023-12-14, status=1, ipAttribution=重庆)]

2024-04-17 Judy Bright 来自广东省

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：肺癌;肿瘤生物学
经验分享：从投稿到目前一审回来一共81天，给了 minor revision，目前在狂补实验，希望后面能顺利🙏
时间线变化如下：
2024.01.25：Submission
2024.01.26：Under Consideration，Editor not Assigned
2024.02.15：Editor Assigned
2024.04.09：Decision Made
2024.04.15：出现一个空的进度条，然后当天晚上收到了小修的邮件，给了三周时间修回
目前正在狂补实验，攒攒人品🙏🙏🙏
顺便问一下，这个期刊小修的话二审会送外审吗？着急毕业 (T_T)

140 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2108140, encodeId=f9532108140cb, content=投稿7天 decision made ，现在12天了，not assigned，未收到邮件，是不是拒了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5285325183, createdName=148b8e1fm60暂无昵称, createdTime=Fri Dec 30 13:11:59 CST 2022, time=2022-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2196205, encodeId=f8ea2196205f2, content=偏重的研究方向：免疫;细胞死亡 经验分享：我的Under Consideration 6天就直接Decision Made，这种情况是被拒了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=313a5603215, createdName=ms3000002118315862, createdTime=Sat Mar 30 11:00:33 CST 2024, time=2024-03-30, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2201464, encodeId=5e49220146419, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43d42425724, createdName=123a6632m26暂无昵称, createdTime=Thu May 02 12:46:37 CST 2024, time=12小时前, status=0, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2198923, encodeId=d299219892362, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肺癌;肿瘤生物学 经验分享：从投稿到目前一审回来一共81天，给了 minor revision，目前在狂补实验，希望后面能顺利🙏 时间线变化如下： 2024.01.25：Submission 2024.01.26：Under Consideration，Editor not Assigned 2024.02.15：Editor Assigned 2024.04.09：Decision Made 2024.04.15：出现一个空的进度条，然后当天晚上收到了小修的邮件，给了三周时间修回 目前正在狂补实验，攒攒人品🙏🙏🙏 顺便问一下，这个期刊小修的话二审会送外审吗？着急毕业 (T_T), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220323/c7cf4e6998eb4c7b9c22a01d070c1561/eac82b677dd4471abc7021cc1ba93665.jpg, createdBy=a70d6506235, createdName=Judy Bright, createdTime=Wed Apr 17 10:23:35 CST 2024, time=2024-04-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2173941, encodeId=78ad21e3941c3, content=偏重的研究方向：心血管 经验分享：请大家留言说说一审多久啊，着急毕业，麻烦啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=97525587163, createdName=ms6000000973811944, createdTime=Sat Dec 09 23:54:03 CST 2023, time=2023-12-09, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2147888, encodeId=f2bd214e88842, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：呼吸疾病 经验分享：刚刚中了一篇，比较顺利, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0578477592, createdName=ms7000000921712169, createdTime=Thu Jul 13 19:57:12 CST 2023, time=2023-07-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2199882, encodeId=e3002199882a3, content=想问问大家这个杂志要求的查重率是多少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43d42425724, createdName=123a6632m26暂无昵称, createdTime=Tue Apr 23 01:01:22 CST 2024, time=2024-04-23, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2199775, encodeId=455e2199e75e5, content=偏重的研究方向：死亡;肾癌 经验分享：不容易, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211224/f0f3cc1077304895a307b4b25ddcac07/13b194375f264471bea86cdd211185d4.jpg, createdBy=e8105550250, createdName=Tassel, createdTime=Mon Apr 22 14:22:31 CST 2024, time=2024-04-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2199774, encodeId=968d2199e74d3, content=比较困难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211224/f0f3cc1077304895a307b4b25ddcac07/13b194375f264471bea86cdd211185d4.jpg, createdBy=e8105550250, createdName=Tassel, createdTime=Mon Apr 22 14:20:44 CST 2024, time=2024-04-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2174840, encodeId=c6b921e48403a, content=偏重的研究方向：肿瘤 经验分享：刚submit，沾沾大家的喜气, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4d02501413, createdName=沧海医僧笑, createdTime=Thu Dec 14 01:51:31 CST 2023, time=2023-12-14, status=1, ipAttribution=重庆)]

2023-12-09 ms6000000973811944 来自辽宁省

偏重的研究方向：心血管
经验分享：请大家留言说说一审多久啊，着急毕业，麻烦啦

46 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2108140, encodeId=f9532108140cb, content=投稿7天 decision made ，现在12天了，not assigned，未收到邮件，是不是拒了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5285325183, createdName=148b8e1fm60暂无昵称, createdTime=Fri Dec 30 13:11:59 CST 2022, time=2022-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2196205, encodeId=f8ea2196205f2, content=偏重的研究方向：免疫;细胞死亡 经验分享：我的Under Consideration 6天就直接Decision Made，这种情况是被拒了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=313a5603215, createdName=ms3000002118315862, createdTime=Sat Mar 30 11:00:33 CST 2024, time=2024-03-30, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2201464, encodeId=5e49220146419, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43d42425724, createdName=123a6632m26暂无昵称, createdTime=Thu May 02 12:46:37 CST 2024, time=12小时前, status=0, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2198923, encodeId=d299219892362, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肺癌;肿瘤生物学 经验分享：从投稿到目前一审回来一共81天，给了 minor revision，目前在狂补实验，希望后面能顺利🙏 时间线变化如下： 2024.01.25：Submission 2024.01.26：Under Consideration，Editor not Assigned 2024.02.15：Editor Assigned 2024.04.09：Decision Made 2024.04.15：出现一个空的进度条，然后当天晚上收到了小修的邮件，给了三周时间修回 目前正在狂补实验，攒攒人品🙏🙏🙏 顺便问一下，这个期刊小修的话二审会送外审吗？着急毕业 (T_T), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220323/c7cf4e6998eb4c7b9c22a01d070c1561/eac82b677dd4471abc7021cc1ba93665.jpg, createdBy=a70d6506235, createdName=Judy Bright, createdTime=Wed Apr 17 10:23:35 CST 2024, time=2024-04-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2173941, encodeId=78ad21e3941c3, content=偏重的研究方向：心血管 经验分享：请大家留言说说一审多久啊，着急毕业，麻烦啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=97525587163, createdName=ms6000000973811944, createdTime=Sat Dec 09 23:54:03 CST 2023, time=2023-12-09, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2147888, encodeId=f2bd214e88842, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：呼吸疾病 经验分享：刚刚中了一篇，比较顺利, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0578477592, createdName=ms7000000921712169, createdTime=Thu Jul 13 19:57:12 CST 2023, time=2023-07-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2199882, encodeId=e3002199882a3, content=想问问大家这个杂志要求的查重率是多少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43d42425724, createdName=123a6632m26暂无昵称, createdTime=Tue Apr 23 01:01:22 CST 2024, time=2024-04-23, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2199775, encodeId=455e2199e75e5, content=偏重的研究方向：死亡;肾癌 经验分享：不容易, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211224/f0f3cc1077304895a307b4b25ddcac07/13b194375f264471bea86cdd211185d4.jpg, createdBy=e8105550250, createdName=Tassel, createdTime=Mon Apr 22 14:22:31 CST 2024, time=2024-04-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2199774, encodeId=968d2199e74d3, content=比较困难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211224/f0f3cc1077304895a307b4b25ddcac07/13b194375f264471bea86cdd211185d4.jpg, createdBy=e8105550250, createdName=Tassel, createdTime=Mon Apr 22 14:20:44 CST 2024, time=2024-04-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2174840, encodeId=c6b921e48403a, content=偏重的研究方向：肿瘤 经验分享：刚submit，沾沾大家的喜气, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4d02501413, createdName=沧海医僧笑, createdTime=Thu Dec 14 01:51:31 CST 2023, time=2023-12-14, status=1, ipAttribution=重庆)]

2023-07-13 ms7000000921712169 来自广东省

审稿速度:3.0 | 投稿命中率:25.0
偏重的研究方向：呼吸疾病
经验分享：刚刚中了一篇，比较顺利

70 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=2108140, encodeId=f9532108140cb, content=投稿7天 decision made ，现在12天了，not assigned，未收到邮件，是不是拒了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5285325183, createdName=148b8e1fm60暂无昵称, createdTime=Fri Dec 30 13:11:59 CST 2022, time=2022-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2196205, encodeId=f8ea2196205f2, content=偏重的研究方向：免疫;细胞死亡 经验分享：我的Under Consideration 6天就直接Decision Made，这种情况是被拒了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=313a5603215, createdName=ms3000002118315862, createdTime=Sat Mar 30 11:00:33 CST 2024, time=2024-03-30, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2201464, encodeId=5e49220146419, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43d42425724, createdName=123a6632m26暂无昵称, createdTime=Thu May 02 12:46:37 CST 2024, time=12小时前, status=0, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2198923, encodeId=d299219892362, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肺癌;肿瘤生物学 经验分享：从投稿到目前一审回来一共81天，给了 minor revision，目前在狂补实验，希望后面能顺利🙏 时间线变化如下： 2024.01.25：Submission 2024.01.26：Under Consideration，Editor not Assigned 2024.02.15：Editor Assigned 2024.04.09：Decision Made 2024.04.15：出现一个空的进度条，然后当天晚上收到了小修的邮件，给了三周时间修回 目前正在狂补实验，攒攒人品🙏🙏🙏 顺便问一下，这个期刊小修的话二审会送外审吗？着急毕业 (T_T), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220323/c7cf4e6998eb4c7b9c22a01d070c1561/eac82b677dd4471abc7021cc1ba93665.jpg, createdBy=a70d6506235, createdName=Judy Bright, createdTime=Wed Apr 17 10:23:35 CST 2024, time=2024-04-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2173941, encodeId=78ad21e3941c3, content=偏重的研究方向：心血管 经验分享：请大家留言说说一审多久啊，着急毕业，麻烦啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=97525587163, createdName=ms6000000973811944, createdTime=Sat Dec 09 23:54:03 CST 2023, time=2023-12-09, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2147888, encodeId=f2bd214e88842, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：呼吸疾病 经验分享：刚刚中了一篇，比较顺利, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0578477592, createdName=ms7000000921712169, createdTime=Thu Jul 13 19:57:12 CST 2023, time=2023-07-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2199882, encodeId=e3002199882a3, content=想问问大家这个杂志要求的查重率是多少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43d42425724, createdName=123a6632m26暂无昵称, createdTime=Tue Apr 23 01:01:22 CST 2024, time=2024-04-23, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2199775, encodeId=455e2199e75e5, content=偏重的研究方向：死亡;肾癌 经验分享：不容易, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211224/f0f3cc1077304895a307b4b25ddcac07/13b194375f264471bea86cdd211185d4.jpg, createdBy=e8105550250, createdName=Tassel, createdTime=Mon Apr 22 14:22:31 CST 2024, time=2024-04-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2199774, encodeId=968d2199e74d3, content=比较困难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211224/f0f3cc1077304895a307b4b25ddcac07/13b194375f264471bea86cdd211185d4.jpg, createdBy=e8105550250, createdName=Tassel, createdTime=Mon Apr 22 14:20:44 CST 2024, time=2024-04-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2174840, encodeId=c6b921e48403a, content=偏重的研究方向：肿瘤 经验分享：刚submit，沾沾大家的喜气, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4d02501413, createdName=沧海医僧笑, createdTime=Thu Dec 14 01:51:31 CST 2023, time=2023-12-14, status=1, ipAttribution=重庆)]

2024-04-23 123a6632m26暂无昵称来自辽宁省

想问问大家这个杂志要求的查重率是多少

4 0

[GetPortalCommentsPageByObjectIdResponse(id=2108140, encodeId=f9532108140cb, content=投稿7天 decision made ，现在12天了，not assigned，未收到邮件，是不是拒了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5285325183, createdName=148b8e1fm60暂无昵称, createdTime=Fri Dec 30 13:11:59 CST 2022, time=2022-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2196205, encodeId=f8ea2196205f2, content=偏重的研究方向：免疫;细胞死亡 经验分享：我的Under Consideration 6天就直接Decision Made，这种情况是被拒了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=313a5603215, createdName=ms3000002118315862, createdTime=Sat Mar 30 11:00:33 CST 2024, time=2024-03-30, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2201464, encodeId=5e49220146419, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43d42425724, createdName=123a6632m26暂无昵称, createdTime=Thu May 02 12:46:37 CST 2024, time=12小时前, status=0, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2198923, encodeId=d299219892362, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肺癌;肿瘤生物学 经验分享：从投稿到目前一审回来一共81天，给了 minor revision，目前在狂补实验，希望后面能顺利🙏 时间线变化如下： 2024.01.25：Submission 2024.01.26：Under Consideration，Editor not Assigned 2024.02.15：Editor Assigned 2024.04.09：Decision Made 2024.04.15：出现一个空的进度条，然后当天晚上收到了小修的邮件，给了三周时间修回 目前正在狂补实验，攒攒人品🙏🙏🙏 顺便问一下，这个期刊小修的话二审会送外审吗？着急毕业 (T_T), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220323/c7cf4e6998eb4c7b9c22a01d070c1561/eac82b677dd4471abc7021cc1ba93665.jpg, createdBy=a70d6506235, createdName=Judy Bright, createdTime=Wed Apr 17 10:23:35 CST 2024, time=2024-04-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2173941, encodeId=78ad21e3941c3, content=偏重的研究方向：心血管 经验分享：请大家留言说说一审多久啊，着急毕业，麻烦啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=97525587163, createdName=ms6000000973811944, createdTime=Sat Dec 09 23:54:03 CST 2023, time=2023-12-09, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2147888, encodeId=f2bd214e88842, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：呼吸疾病 经验分享：刚刚中了一篇，比较顺利, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0578477592, createdName=ms7000000921712169, createdTime=Thu Jul 13 19:57:12 CST 2023, time=2023-07-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2199882, encodeId=e3002199882a3, content=想问问大家这个杂志要求的查重率是多少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43d42425724, createdName=123a6632m26暂无昵称, createdTime=Tue Apr 23 01:01:22 CST 2024, time=2024-04-23, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2199775, encodeId=455e2199e75e5, content=偏重的研究方向：死亡;肾癌 经验分享：不容易, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211224/f0f3cc1077304895a307b4b25ddcac07/13b194375f264471bea86cdd211185d4.jpg, createdBy=e8105550250, createdName=Tassel, createdTime=Mon Apr 22 14:22:31 CST 2024, time=2024-04-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2199774, encodeId=968d2199e74d3, content=比较困难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211224/f0f3cc1077304895a307b4b25ddcac07/13b194375f264471bea86cdd211185d4.jpg, createdBy=e8105550250, createdName=Tassel, createdTime=Mon Apr 22 14:20:44 CST 2024, time=2024-04-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2174840, encodeId=c6b921e48403a, content=偏重的研究方向：肿瘤 经验分享：刚submit，沾沾大家的喜气, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4d02501413, createdName=沧海医僧笑, createdTime=Thu Dec 14 01:51:31 CST 2023, time=2023-12-14, status=1, ipAttribution=重庆)]

2024-04-22 Tassel 来自北京

偏重的研究方向：死亡;肾癌
经验分享：不容易

7 0

[GetPortalCommentsPageByObjectIdResponse(id=2108140, encodeId=f9532108140cb, content=投稿7天 decision made ，现在12天了，not assigned，未收到邮件，是不是拒了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5285325183, createdName=148b8e1fm60暂无昵称, createdTime=Fri Dec 30 13:11:59 CST 2022, time=2022-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2196205, encodeId=f8ea2196205f2, content=偏重的研究方向：免疫;细胞死亡 经验分享：我的Under Consideration 6天就直接Decision Made，这种情况是被拒了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=313a5603215, createdName=ms3000002118315862, createdTime=Sat Mar 30 11:00:33 CST 2024, time=2024-03-30, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2201464, encodeId=5e49220146419, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43d42425724, createdName=123a6632m26暂无昵称, createdTime=Thu May 02 12:46:37 CST 2024, time=12小时前, status=0, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2198923, encodeId=d299219892362, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肺癌;肿瘤生物学 经验分享：从投稿到目前一审回来一共81天，给了 minor revision，目前在狂补实验，希望后面能顺利🙏 时间线变化如下： 2024.01.25：Submission 2024.01.26：Under Consideration，Editor not Assigned 2024.02.15：Editor Assigned 2024.04.09：Decision Made 2024.04.15：出现一个空的进度条，然后当天晚上收到了小修的邮件，给了三周时间修回 目前正在狂补实验，攒攒人品🙏🙏🙏 顺便问一下，这个期刊小修的话二审会送外审吗？着急毕业 (T_T), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220323/c7cf4e6998eb4c7b9c22a01d070c1561/eac82b677dd4471abc7021cc1ba93665.jpg, createdBy=a70d6506235, createdName=Judy Bright, createdTime=Wed Apr 17 10:23:35 CST 2024, time=2024-04-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2173941, encodeId=78ad21e3941c3, content=偏重的研究方向：心血管 经验分享：请大家留言说说一审多久啊，着急毕业，麻烦啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=97525587163, createdName=ms6000000973811944, createdTime=Sat Dec 09 23:54:03 CST 2023, time=2023-12-09, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2147888, encodeId=f2bd214e88842, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：呼吸疾病 经验分享：刚刚中了一篇，比较顺利, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0578477592, createdName=ms7000000921712169, createdTime=Thu Jul 13 19:57:12 CST 2023, time=2023-07-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2199882, encodeId=e3002199882a3, content=想问问大家这个杂志要求的查重率是多少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43d42425724, createdName=123a6632m26暂无昵称, createdTime=Tue Apr 23 01:01:22 CST 2024, time=2024-04-23, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2199775, encodeId=455e2199e75e5, content=偏重的研究方向：死亡;肾癌 经验分享：不容易, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211224/f0f3cc1077304895a307b4b25ddcac07/13b194375f264471bea86cdd211185d4.jpg, createdBy=e8105550250, createdName=Tassel, createdTime=Mon Apr 22 14:22:31 CST 2024, time=2024-04-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2199774, encodeId=968d2199e74d3, content=比较困难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211224/f0f3cc1077304895a307b4b25ddcac07/13b194375f264471bea86cdd211185d4.jpg, createdBy=e8105550250, createdName=Tassel, createdTime=Mon Apr 22 14:20:44 CST 2024, time=2024-04-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2174840, encodeId=c6b921e48403a, content=偏重的研究方向：肿瘤 经验分享：刚submit，沾沾大家的喜气, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4d02501413, createdName=沧海医僧笑, createdTime=Thu Dec 14 01:51:31 CST 2023, time=2023-12-14, status=1, ipAttribution=重庆)]

2024-04-22 Tassel 来自北京

比较困难

4 0

[GetPortalCommentsPageByObjectIdResponse(id=2108140, encodeId=f9532108140cb, content=投稿7天 decision made ，现在12天了，not assigned，未收到邮件，是不是拒了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5285325183, createdName=148b8e1fm60暂无昵称, createdTime=Fri Dec 30 13:11:59 CST 2022, time=2022-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2196205, encodeId=f8ea2196205f2, content=偏重的研究方向：免疫;细胞死亡 经验分享：我的Under Consideration 6天就直接Decision Made，这种情况是被拒了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=313a5603215, createdName=ms3000002118315862, createdTime=Sat Mar 30 11:00:33 CST 2024, time=2024-03-30, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2201464, encodeId=5e49220146419, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43d42425724, createdName=123a6632m26暂无昵称, createdTime=Thu May 02 12:46:37 CST 2024, time=12小时前, status=0, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2198923, encodeId=d299219892362, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肺癌;肿瘤生物学 经验分享：从投稿到目前一审回来一共81天，给了 minor revision，目前在狂补实验，希望后面能顺利🙏 时间线变化如下： 2024.01.25：Submission 2024.01.26：Under Consideration，Editor not Assigned 2024.02.15：Editor Assigned 2024.04.09：Decision Made 2024.04.15：出现一个空的进度条，然后当天晚上收到了小修的邮件，给了三周时间修回 目前正在狂补实验，攒攒人品🙏🙏🙏 顺便问一下，这个期刊小修的话二审会送外审吗？着急毕业 (T_T), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220323/c7cf4e6998eb4c7b9c22a01d070c1561/eac82b677dd4471abc7021cc1ba93665.jpg, createdBy=a70d6506235, createdName=Judy Bright, createdTime=Wed Apr 17 10:23:35 CST 2024, time=2024-04-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2173941, encodeId=78ad21e3941c3, content=偏重的研究方向：心血管 经验分享：请大家留言说说一审多久啊，着急毕业，麻烦啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=97525587163, createdName=ms6000000973811944, createdTime=Sat Dec 09 23:54:03 CST 2023, time=2023-12-09, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2147888, encodeId=f2bd214e88842, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：呼吸疾病 经验分享：刚刚中了一篇，比较顺利, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0578477592, createdName=ms7000000921712169, createdTime=Thu Jul 13 19:57:12 CST 2023, time=2023-07-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2199882, encodeId=e3002199882a3, content=想问问大家这个杂志要求的查重率是多少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43d42425724, createdName=123a6632m26暂无昵称, createdTime=Tue Apr 23 01:01:22 CST 2024, time=2024-04-23, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2199775, encodeId=455e2199e75e5, content=偏重的研究方向：死亡;肾癌 经验分享：不容易, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211224/f0f3cc1077304895a307b4b25ddcac07/13b194375f264471bea86cdd211185d4.jpg, createdBy=e8105550250, createdName=Tassel, createdTime=Mon Apr 22 14:22:31 CST 2024, time=2024-04-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2199774, encodeId=968d2199e74d3, content=比较困难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211224/f0f3cc1077304895a307b4b25ddcac07/13b194375f264471bea86cdd211185d4.jpg, createdBy=e8105550250, createdName=Tassel, createdTime=Mon Apr 22 14:20:44 CST 2024, time=2024-04-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2174840, encodeId=c6b921e48403a, content=偏重的研究方向：肿瘤 经验分享：刚submit，沾沾大家的喜气, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4d02501413, createdName=沧海医僧笑, createdTime=Thu Dec 14 01:51:31 CST 2023, time=2023-12-14, status=1, ipAttribution=重庆)]

2023-12-14 沧海医僧笑来自重庆

偏重的研究方向：肿瘤
经验分享：刚submit，沾沾大家的喜气

56 8

展开8条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务